Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Dutogliptin Tartrate

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clinical Trial Outcomes of Recardio's Dutogliptin Published in the BJOP
    Clinical Trial Outcomes of Recardio's Dutogliptin Published in the BJOP

    18 May 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/clinical-trial-outcomes-of-recardios-dutogliptin-published-in-the-british-journal-of-pharmacology-301060817.html

    PRNEWSWIRE
    18 May 2020
    Share Share
    Recardio halts UK heart trial on Brexit uncertainty
    Recardio halts UK heart trial on Brexit uncertainty

    03 Oct 2018

    // Selina McKee PHARMA TIMES

    http://www.pharmatimes.com/news/recardio_halts_uk_heart_trial_on_brexit_uncertainty_1254424

    Selina McKee PHARMA TIMES
    03 Oct 2018
    Share Share